Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BerGenBio AS (BRRGF)
OTHER OTC:BRRGF
BerGenBio AS (BRRGF) Stock Price & Analysis
38 Followers
BRRGF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.03 - $0.14
Previous Close$0.03
Volume37.30K
Average Volume (3M)N/A
Market Cap
$39.65M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-0.7
Beta0.41
Next Earnings
May 29, 2024EPS Estimate
>-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding88,660,532
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.60
R-Squared0.00094
Alpha-0.00157
Financial Highlights & Ratios
Price to Book (P/B)2.42
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.18Price Target Upside620.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
BerGenBio AS News
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.03% Mutual Funds
0.06% Other Institutional Investors
99.92% Public Companies and
Individual Investors
BRRGF FAQ
What was BerGenBio AS’s price range in the past 12 months?
BerGenBio AS lowest stock price was $0.03 and its highest was $0.14 in the past 12 months.
What is BerGenBio AS’s market cap?
Currently, no data Available
When is BerGenBio AS’s upcoming earnings report date?
BerGenBio AS’s upcoming earnings report date is May 29, 2024 which is in 40 days.
How were BerGenBio AS’s earnings last quarter?
BerGenBio AS released its earnings results on Feb 14, 2024. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of >-$0.001 by >-$0.001.
Is BerGenBio AS overvalued?
According to Wall Street analysts BerGenBio AS’s price is currently Undervalued.
Does BerGenBio AS pay dividends?
BerGenBio AS does not currently pay dividends.
What is BerGenBio AS’s EPS estimate?
BerGenBio AS’s EPS estimate is >-$0.01.
How many shares outstanding does BerGenBio AS have?
BerGenBio AS has 2,688,689,200 shares outstanding.
What happened to BerGenBio AS’s price movement after its last earnings report?
BerGenBio AS reported an EPS of -$0.002 in its last earnings report, missing expectations of >-$0.001. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BerGenBio AS?
Currently, no hedge funds are holding shares in BRRGF
---
BerGenBio AS Stock Smart Score
Company Description
BerGenBio AS
BerGenBio ASA is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers.
---
BRRGF Company Deck
---
BRRGF Earnings Call
Q4 2024
0:00 / 0:00
---
BRRGF Stock 12 Months Forecast
Average Price Target
$0.18
▲(620.00% Upside)
Technical Analysis
Best Analysts Covering BRRGF
1 Year
1 Year Success Rate
1/9 ratings generated profit
1 Year Average Return
-38.07%
reiterated a buy rating 29 days ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -38.07% per trade.
---